169 related articles for article (PubMed ID: 3759363)
1. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
3. Ocular penetration of (125I)IVDU, a radiolabeled analogue of bromovinyldeoxyuridine.
Maudgal PC; Verbruggen AM; De Clercq E; Busson R; Bernaerts R; de Roo M; Ameye C; Missotten L
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):45-9. PubMed ID: 3967955
[TBL] [Abstract][Full Text] [Related]
4. Trifluorothymidine treatment of herpetic iritis in rabbits and ocular penetration.
Sugar J; Varnell E; Centifanto Y; Kaufman HE
Invest Ophthalmol; 1973 Jul; 12(7):532-4. PubMed ID: 4742994
[No Abstract] [Full Text] [Related]
5. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
6. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
7. Adenine arabinoside therapy in corneal stromal disease and iritis due to herpes simplex.
Brightbill FS; Kaufman HE
Ann Ophthalmol; 1974 Jan; 6(1):25-32. PubMed ID: 4359979
[No Abstract] [Full Text] [Related]
8. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
9. Oral and topical treatment of experimental herpes simplex iritis with bromovinyldeoxyuridine.
Maudgal PC; Uyttebroeck W; De Clercq E; Missotten L
Arch Ophthalmol; 1982 Aug; 100(8):1337-40. PubMed ID: 6808980
[No Abstract] [Full Text] [Related]
10. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits].
Bogdanova NS; Nikolaeva IS; Pershin GN
Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
Maudgal PC; De Clercq E; Descamps J; Missotten L
Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
[No Abstract] [Full Text] [Related]
12. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
13. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
Maudgal PC; De Clercq E; Huyghe P
Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
15. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and antiviral activity of riodoksol in an ointment and in ophthalmic drug films in ocular herpes].
Shchipanova AI; Maĭchuk IuF; Nikolaeva IS; Pershin GN
Farmakol Toksikol; 1981; 44(4):439-42. PubMed ID: 7286202
[TBL] [Abstract][Full Text] [Related]
17. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
19. [Concentration dependent effect of 5-ethyl-2'-deoxyuridine on experimental and clinical herpetic keratitis (author's transl)].
Gauri KK; Elze K-L
Klin Monbl Augenheilkd; 1977 Sep; 171(3):459-63. PubMed ID: 926649
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
Maudgal PC; De Clercq E; Missotten L
Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
